...
search icon
aim-img

AIM ImmunoTech Inc Share Price

AIM
ASQ
$1.19
+$0.04
(3.48%)
1D
Industry: Biotechnology Sector: Health Care

AIM ImmunoTech Inc Analyst Forecast

AIM ImmunoTech Inc Share Price Chart

AIM ImmunoTech Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$3.91M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
263.60K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.24
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.77 L
$15.85 H
$1.19

About AIM ImmunoTech Inc, Common Stock

AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. Its flagship products are Ampligen (rintatolimod), a drug of large macromolecular double-stranded ribonucleic acid molecules to treat chronic fatigue syndrome; and Alferon N Injection (Interferon alfa), a purified, natural-source, glycosylated, multi-species alpha interferon product for the treatment of genital warts. The company is also developing Ampligen for potential treatment of pancreatic, renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as for myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. The company was formerly known as Hemispherx Biopharma, Inc. and changed its name to AIM ImmunoTech Inc. in August 2019. AIM ImmunoTech Inc. was incorporated in 1966 and is headquartered in Ocala, Florida. more

Industry: BiotechnologySector: Health Care

AIM ImmunoTech Inc Stock Returns

Time FrameAIMSectorS&P500
1-Week Return36.3%0.72%-1.31%
1-Month Return-2.54%1.27%0.78%
3-Month Return-13.45%3.13%3.46%
6-Month Return-51.22%15.81%6.19%
1-Year Return-91.6%8.89%11.68%
3-Year Return-97.72%20.79%71.21%
5-Year Return-99.54%35.89%74.81%
10-Year Return-99.98%138.44%256.59%

AIM ImmunoTech Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue163.00K135.00K141.00K202.00K170.00K[{"date":"2020-12-31","value":80.69,"profit":true},{"date":"2021-12-31","value":66.83,"profit":true},{"date":"2022-12-31","value":69.8,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":84.16,"profit":true}]
Cost of Revenue806.00K850.00K(424.00K)42.00K31.00K[{"date":"2020-12-31","value":94.82,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-49.88,"profit":false},{"date":"2023-12-31","value":4.94,"profit":true},{"date":"2024-12-31","value":3.65,"profit":true}]
Gross Profit(643.00K)(715.00K)565.00K160.00K139.00K[{"date":"2020-12-31","value":-113.81,"profit":false},{"date":"2021-12-31","value":-126.55,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":28.32,"profit":true},{"date":"2024-12-31","value":24.6,"profit":true}]
Gross Margin(394.48%)(529.63%)400.71%79.21%81.76%[{"date":"2020-12-31","value":-98.45,"profit":false},{"date":"2021-12-31","value":-132.17,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":19.77,"profit":true},{"date":"2024-12-31","value":20.4,"profit":true}]
Operating Expenses14.51M18.12M20.49M32.08M19.91M[{"date":"2020-12-31","value":45.23,"profit":true},{"date":"2021-12-31","value":56.5,"profit":true},{"date":"2022-12-31","value":63.87,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":62.07,"profit":true}]
Operating Income(15.15M)(18.84M)(19.92M)(31.92M)(19.77M)[{"date":"2020-12-31","value":-1515200000,"profit":false},{"date":"2021-12-31","value":-1883800000,"profit":false},{"date":"2022-12-31","value":-1992281000,"profit":false},{"date":"2023-12-31","value":-3191600000,"profit":false},{"date":"2024-12-31","value":-1977200000,"profit":false}]
Total Non-Operating Income/Expense80.00K(356.00K)1.11M4.02M7.06M[{"date":"2020-12-31","value":1.13,"profit":true},{"date":"2021-12-31","value":-5.04,"profit":false},{"date":"2022-12-31","value":15.68,"profit":true},{"date":"2023-12-31","value":56.99,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(14.40M)(19.13M)(19.45M)(28.96M)(17.32M)[{"date":"2020-12-31","value":-1440000000,"profit":false},{"date":"2021-12-31","value":-1912700000,"profit":false},{"date":"2022-12-31","value":-1944500000,"profit":false},{"date":"2023-12-31","value":-2896200000,"profit":false},{"date":"2024-12-31","value":-1732000000,"profit":false}]
Income Taxes1.86M2.39M1.64M--[{"date":"2020-12-31","value":77.87,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":68.78,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(16.26M)(21.51M)(21.09M)--[{"date":"2020-12-31","value":-1625800000,"profit":false},{"date":"2021-12-31","value":-2151300000,"profit":false},{"date":"2022-12-31","value":-2108600000,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(14.40M)(19.13M)(19.45M)(28.96M)(17.32M)[{"date":"2020-12-31","value":-1440000000,"profit":false},{"date":"2021-12-31","value":-1912700000,"profit":false},{"date":"2022-12-31","value":-1944500000,"profit":false},{"date":"2023-12-31","value":-2896200000,"profit":false},{"date":"2024-12-31","value":-1732000000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(14.40M)(19.13M)(19.45M)(28.96M)(17.32M)[{"date":"2020-12-31","value":-1440000000,"profit":false},{"date":"2021-12-31","value":-1912700000,"profit":false},{"date":"2022-12-31","value":-1944500000,"profit":false},{"date":"2023-12-31","value":-2896200000,"profit":false},{"date":"2024-12-31","value":-1732000000,"profit":false}]
EPS (Diluted)(0.50)-(0.68)(0.62)(10.37)[{"date":"2020-12-31","value":-50,"profit":false},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-68,"profit":false},{"date":"2023-12-31","value":-62.22,"profit":false},{"date":"2024-12-31","value":-1036.89,"profit":false}]

AIM ImmunoTech Inc Ratios

AIM ImmunoTech Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

AIM
Cash Ratio 0.60
Current Ratio 0.64

AIM ImmunoTech Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

AIM
ROA (LTM) -95.42%
ROE (LTM) -3138.91%

AIM ImmunoTech Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

AIM
Debt Ratio Lower is generally better. Negative is bad. 2.11
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -1.11

AIM ImmunoTech Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

AIM
Trailing PE NM
Forward PE NM
P/S (TTM) 34.95
P/B 2.72
Price/FCF NM
EV/R 37.35
EV/Ebitda 0.49

FAQs

What is AIM ImmunoTech Inc share price today?

AIM ImmunoTech Inc (AIM) share price today is $1.19

Can Indians buy AIM ImmunoTech Inc shares?

Yes, Indians can buy shares of AIM ImmunoTech Inc (AIM) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in AIM stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of AIM ImmunoTech Inc be purchased?

Yes, you can purchase fractional shares of AIM ImmunoTech Inc (AIM) via the Vested app. You can start investing in AIM ImmunoTech Inc (AIM) with a minimum investment of $1.

How to invest in AIM ImmunoTech Inc shares from India?

You can invest in shares of AIM ImmunoTech Inc (AIM) via Vested in three simple steps:

  • Click on Sign Up or Invest in AIM stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in AIM ImmunoTech Inc shares
What is AIM ImmunoTech Inc 52-week high and low stock price?

The 52-week high price of AIM ImmunoTech Inc (AIM) is $15.85. The 52-week low price of AIM ImmunoTech Inc (AIM) is $0.77.

What is AIM ImmunoTech Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of AIM ImmunoTech Inc (AIM) is

What is AIM ImmunoTech Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of AIM ImmunoTech Inc (AIM) is 2.72

What is AIM ImmunoTech Inc dividend yield?

The dividend yield of AIM ImmunoTech Inc (AIM) is 0.00%

What is the Market Cap of AIM ImmunoTech Inc?

The market capitalization of AIM ImmunoTech Inc (AIM) is $3.91M

What is AIM ImmunoTech Inc's stock symbol?

The stock symbol (or ticker) of AIM ImmunoTech Inc is AIM

How Can Investors Use AIM ImmunoTech Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of AIM ImmunoTech Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether AIM ImmunoTech Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from AIM ImmunoTech Inc shares for Indian investors?

When investing in AIM ImmunoTech Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the AIM ImmunoTech Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare AIM ImmunoTech Inc share price with other stocks in the same sector?

Rather than merely checking the share price of AIM ImmunoTech Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that AIM ImmunoTech Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top